Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
What is COPD?
COPD stands for chronic obstructive pulmonary disease. It's actually an umbrella term for two conditions: emphysema, where the tiny air sacs in the lungs get destroyed, and chronic bronchitis, where the airways stay inflamed and clogged with mucus. Both make it harder to breathe. Smoking is the main cause in the US, but not the only one. Air pollution, workplace dust and fumes, and a genetic condition called alpha-1 antitrypsin deficiency can cause it too. Some people with COPD never smoked.
A few things make COPD research unusual. Most studies don't test a drug at all, they test breathing devices, oxygen equipment, and rehab programs. Drug trials tend to run long, often about a year per participant, since what they're tracking is flare ups, and those don't happen on a schedule. Researchers are also working to close a gap: COPD rates run higher in rural areas and in American Indian and Alaska Native communities, groups that trials have historically missed.
What are the signs and symptoms of COPD?
Common symptoms include shortness of breath, especially during physical activity, an ongoing cough or a cough that brings up a lot of mucus, wheezing, chest tightness or heaviness, and tiredness. The ongoing cough is often the first symptom people notice. Some of these symptoms overlap with asthma, and the two conditions can even occur together, a mix doctors call asthma-COPD overlap. And at the start, COPD may cause no symptoms at all, or only mild ones, which is one reason stage 1 so often goes unnoticed.
Can COPD be reversed?
No. COPD cannot be reversed, and there is no cure yet. The narrowing in the airways is persistent: it does not go back to normal, even with medicine. But treatment and lifestyle changes such as quitting smoking can slow the disease down and ease symptoms.
Types of COPD clinical trials
Types of COPD clinical trials include a wide range of studies focused on improving treatment and management of the disease. These trials test new medications and inhaler technologies, assess physical therapy and rehabilitation programs, explore oxygen and ventilatory support options, evaluate the effectiveness of surgical and interventional procedures, and examine lifestyle and behavioral changes. Each type of trial aims to find better ways to manage COPD symptoms, enhance patient quality of life, and slow disease progression.
Trials focused on medication and inhaler therapies
These trials evaluate new drugs or combinations of medications administered through inhalers, aiming to reduce the frequency of COPD flare-ups, improve lung function, and alleviate symptoms. They often explore the efficacy of bronchodilators, corticosteroids, and other pharmacological treatments in managing COPD.
Physical therapy and rehabilitation trials
Rehabilitation trials investigate the benefits of physical therapy programs, including exercises designed to enhance respiratory function, increase stamina, and improve overall physical fitness in COPD patients. These studies assess how rehabilitation impacts the quality of life, exercise tolerance, and disease progression.
Oxygen and ventilatory support trials
These studies explore the effectiveness of supplemental oxygen therapy and mechanical ventilatory support in individuals with COPD, particularly those with severe disease. Trials may investigate the optimal timing, delivery methods, and outcomes of using oxygen therapy and non-invasive ventilation to manage chronic respiratory failure.
Surgical and interventional procedures trials
Trials exploring surgical and interventional procedures assess the outcomes of surgical and minimally invasive procedures, such as lung volume reduction surgery (LVRS), bullectomy, or endobronchial valve placement. These studies aim to determine how well these interventions improve breathing, reduce symptoms, and enhance the quality of life for patients with advanced COPD.
Lifestyle and behavioral modification trials
Lifestyle and behavioral modification trials examine the impact of dietary changes, smoking cessation, stress management and other lifestyle interventions on COPD management. They investigate how behavioral interventions can affect disease progression, symptom control, and overall well-being.
Who can participate in COPD clinical trials?
It depends on the study. Most COPD drug studies ask for a few of the same things: a diagnosis confirmed by spirometry, your GOLD stage, your smoking history in pack years, and how many flare ups you had in the past year. A smoking history of 10 or more pack years is a common cutoff. Some of the newer biologic studies also need a blood test result, because those medicines only work for people with one specific inflammation pattern. Device, monitoring, and rehab studies on this page usually have simpler requirements, and later stage COPD does not shut the door, studies in this field often look for people with more severe disease. Researchers also want to enroll more people from rural areas and from American Indian and Alaska Native communities, which studies have long struggled to reach. Eligibility always varies by study.
How to enroll in a COPD clinical trial
Enrolling in a COPD clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.
Do COPD trial participants get paid?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.